Total Payments
$24,185
2024 Payments
$1,093
Companies
36
Transactions
357
Medicare Patients
2,909
Medicare Billing
$447,115
Payment Breakdown by Category
Other$14,240 (58.9%)
Food & Beverage$7,134 (29.5%)
Travel$2,721 (11.3%)
Education$89.92 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,240 | 8 | 58.9% |
| Food and Beverage | $7,134 | 332 | 29.5% |
| Travel and Lodging | $2,721 | 13 | 11.3% |
| Education | $89.92 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $15,643 | 53 | $0 (2019) |
| GlaxoSmithKline, LLC. | $3,529 | 66 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,238 | 54 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,101 | 59 | $0 (2024) |
| Amgen Inc. | $250.22 | 9 | $0 (2024) |
| GENZYME CORPORATION | $246.90 | 9 | $0 (2024) |
| Mylan Specialty L.P. | $230.43 | 13 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $217.91 | 8 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $172.68 | 9 | $0 (2023) |
| Grifols USA, LLC | $157.11 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,093 | 43 | AstraZeneca Pharmaceuticals LP ($255.82) |
| 2023 | $1,806 | 72 | AstraZeneca Pharmaceuticals LP ($606.81) |
| 2022 | $1,209 | 64 | Boehringer Ingelheim Pharmaceuticals, Inc. ($262.08) |
| 2021 | $868.43 | 51 | Boehringer Ingelheim Pharmaceuticals, Inc. ($227.76) |
| 2020 | $2,779 | 23 | GlaxoSmithKline, LLC. ($2,515) |
| 2019 | $417.52 | 29 | GlaxoSmithKline, LLC. ($170.21) |
| 2018 | $3,276 | 25 | Sunovion Pharmaceuticals Inc. ($3,094) |
| 2017 | $12,735 | 50 | Sunovion Pharmaceuticals Inc. ($12,493) |
All Payment Transactions
357 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Pulmonology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: NEUROLOGY | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.61 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Pulmonology | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.74 | General |
| 10/08/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Airway Clearance Device | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Immunology | ||||||
| 08/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.52 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/16/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $78.99 | General |
| Category: Immunology | ||||||
| 07/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.82 | General |
| Category: Immunology | ||||||
| 07/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Immunology | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Respiratory | ||||||
| 07/03/2024 | Resmed Corp | AIRSENSE (Device) | Food and Beverage | Cash or cash equivalent | $14.91 | General |
| Category: Sleep | ||||||
| 06/03/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 610 | 939 | $338,517 | $90,270 |
| 2022 | 14 | 690 | 1,085 | $429,294 | $105,891 |
| 2021 | 11 | 768 | 1,129 | $431,338 | $111,086 |
| 2020 | 11 | 841 | 1,423 | $364,742 | $139,867 |
Total Patients
2,909
Total Services
4,576
Medicare Billing
$447,115
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 201 | 346 | $124,176 | $32,806 | 26.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 62 | 189 | $58,923 | $17,400 | 29.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 25 | 61 | $38,281 | $9,904 | 25.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 68 | $34,867 | $9,087 | 26.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 52 | 54 | $28,128 | $7,089 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $23,811 | $6,056 | 25.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $7,144 | $1,646 | 23.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 35 | 35 | $5,556 | $1,569 | 28.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 35 | 35 | $5,419 | $1,504 | 27.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 38 | 38 | $5,138 | $1,160 | 22.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 18 | $3,651 | $1,119 | 30.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 35 | 35 | $3,423 | $929.60 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 201 | 333 | $130,458 | $31,938 | 24.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 70 | 269 | $80,969 | $21,626 | 26.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 86 | 106 | $57,982 | $14,504 | 25.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 31 | 74 | $59,570 | $12,567 | 21.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 49 | 49 | $28,812 | $7,632 | 26.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $20,002 | $4,965 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $19,266 | $4,860 | 25.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 40 | 40 | $6,480 | $1,836 | 28.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 37 | 37 | $6,031 | $1,584 | 26.3% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 12 | 12 | $6,072 | $1,556 | 25.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 41 | 41 | $7,585 | $1,258 | 16.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 29 | 29 | $2,987 | $749.81 | 25.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 13 | $2,730 | $725.17 | 26.6% |
About Dr. Amsel Siore, MD
Dr. Amsel Siore, MD is a Pulmonary Disease healthcare provider based in Snellville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013097971.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amsel Siore, MD has received a total of $24,185 in payments from pharmaceutical and medical device companies, with $1,093 received in 2024. These payments were reported across 357 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,240).
As a Medicare-enrolled provider, Siore has provided services to 2,909 Medicare beneficiaries, totaling 4,576 services with total Medicare billing of $447,115. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Snellville, GA
- Active Since 10/16/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1013097971
Products in Payments
- UTIBRON (Drug) $12,493
- LONHALA MAGNAIR (Drug) $3,098
- TRELEGY ELLIPTA (Drug) $3,002
- OFEV (Drug) $620.70
- TEZSPIRE (Biological) $554.58
- DUPIXENT (Biological) $543.80
- STIOLTO RESPIMAT (Drug) $383.44
- FASENRA (Biological) $377.00
- BREZTRI (Drug) $358.05
- NUCALA (Biological) $267.17
- Yupelri (Drug) $188.23
- ACTHAR (Biological) $172.68
- Prolastin-C Liquid (Biological) $132.47
- XARELTO (Drug) $128.16
- INSPIRE (Device) $102.85
- ANORO ELLIPTA (Drug) $96.11
- XOLAIR (Biological) $94.41
- GLASSIA (Biological) $92.71
- TYVASO (Drug) $84.33
- WAKIX (Drug) $80.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Snellville
Dr. Gregory Mauldin, Md, MD
Pulmonary Disease — Payments: $432,873
Pulmonary Disease $432,873
Douglas Isenstein, Md, MD
Pulmonary Disease — Payments: $2,743
Pulmonary Disease $2,743
Ali Saligheh Araghi, Md, MD
Pulmonary Disease — Payments: $1,421
Pulmonary Disease $1,421
Susan Grey, Md, MD
Pulmonary Disease
Pulmonary Disease